AGPS: A Protein Targeted for Drug Development and Biomarker Research

Target Name: AGPS

NCBI ID: G8540

AGPS

AGPS: A Protein Targeted for Drug Development and Biomarker Research

AGPS (Altered-G protein coupled receptor) is a protein that is located on the surface of many different cell types in the body. It is a key regulator of cell signaling, and is involved in a wide range of physiological processes, including cell growth, differentiation, and survival. AGPS has also been identified as a potential drug target, due to its involvement in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The AGPS protein is composed of 21 different genes, and is expressed in many different tissues and cell types in the body. It is primarily located on the surface of cells in the brain, testes, and placenta, and is also expressed in other tissues, such as the liver, muscle, and heart. AGPS is a transmembrane protein, meaning that it spans the cell membrane and is involved in the exchange of materials between the cell interior and the cell exterior.

AGPS is involved in a wide range of signaling pathways in the body. It is a negative regulator of the RAS/MAPK signaling pathway, which is involved in cell signaling and growth. AGPS helps to regulate the activity of the RAS/MAPK pathway by blocking the activity of the protein kinase kinase (PKC), which is a key regulator of the pathway. This means that AGPS helps to prevent the growth and proliferation of cells that are dependent on the RAS/MAPK pathway.

AGPS is also involved in the regulation of cell adhesion. It is a critical regulator of the cadherin protein, which is involved in cell-cell adhesion and helps to maintain the structure and function of tissues. AGPS helps to regulate the activity of the cadherin protein by interacting with its extracellular domain. This interaction allows AGPS to regulate the level of cadherin protein in cells, which in turn affects the strength and stability of cell-cell adhesion.

In addition to its role in cell signaling and adhesion, AGPS is also involved in the regulation of cell survival. It is a positive regulator of the p53 gene, which is involved in the regulation of DNA damage repair and cell survival. AGPS helps to regulate the activity of the p53 gene by binding to its DNA binding domain. This interaction allows AGPS to promote the activity of the p53 gene, which in turn helps to protect cells from the harmful effects of DNA damage.

Due to its involvement in a wide range of physiological processes, AGPS has been identified as a potential drug target. Many studies have suggested that AGPS may be involved in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, AGPS has been shown to be involved in the development and progression of colon cancer, and may also play a role in the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, AGPS is also an attractive biomarker for a variety of diseases. The AGPS gene is highly conserved across many different species, which means that it is unlikely to have a large number of genetic variations that could be used to diagnose or predict the severity of a disease. Additionally, AGPS is a protein that is expressed in many different tissues and cells in the body, which makes it an attractive target for diagnostic tests that are based on the analysis of protein levels in different tissues.

Overall, AGPS is a protein that is involved in a wide range of physiological processes in the body. Its involvement in cell signaling, adhesion, and survival makes it a potential drug target and an attractive biomarker for a variety of diseases. Further research is needed to fully understand the role of AGPS in the regulation of cell biology and the development of diseases.

Protein Name: Alkylglycerone Phosphate Synthase

Functions: Catalyzes the exchange of the acyl chain in acyl-dihydroxyacetonephosphate (acyl-DHAP) for a long chain fatty alcohol, yielding the first ether linked intermediate, i.e. alkyl-dihydroxyacetonephosphate (alkyl-DHAP), in the pathway of ether lipid biosynthesis

The "AGPS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AGPS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets